A previous cross-sectional study, however, showed that serum A-FABP was correlated closely with risk factors characterized by abdominal obesity, including insulin resistance, hyperglycemia, increased serum triglyceride, LDL-cholesterol, and decreased HDL-cholesterol[9]. Here, FABP4 is linked to Hyperglycemia.